Oculus Innovative Sciences, Inc. - Press Releases

Press Releases

= Add Release to Briefcase

DATE

TITLE



Dec 24, 2012	In Preparation for European Partnership, Oculus Innovative Sciences Expects Expanded Label Claim for European Formulation of Dermacyn™ Wound Care	12.6 KB



Dec 11, 2012	Oculus Innovative Sciences Provides Second Half CY 2012 Business Update	17.5 KB



Nov 27, 2012	Oculus Innovative Sciences to Host New York City Financial Analysts Presentation on November 28, 2012	13.5 KB



Nov 26, 2012	Oculus Innovative Sciences to Create Subsidiary for Company's Anti-Infective Drug Assets	12.7 KB



Nov 14, 2012	Oculus Innovative Sciences Completes Patient Enrollment in Study of Microcyn® Hydrogel in Management of Scars	13.4 KB



Nov 8, 2012	Oculus Innovative Sciences to Host New York City Financial Analysts Presentation on November 28, 2012	13.6 KB



Nov 5, 2012	Oculus Innovative Sciences Achieves Net Worth of $4.5 Million Pro Forma as of September 30, 2012 and Regains Compliance with the Stockholders' Requirement of the NASDAQ Listing Rules	13.5 KB



Nov 2, 2012	Oculus Innovative Sciences to Reschedule New York City Financial Analysts Presentation Originally Scheduled for November 5th Due to Impact of Storm Sandy	9.5 KB



Nov 1, 2012	Oculus Innovative Sciences Reports Record Revenues of $4.5 Million for the Second Quarter of Fiscal 2013	32.1 KB

Oct 25, 2012

Oculus Innovative Sciences to Host New York City Financial Analysts Presentation on November 5, 2012

PDF

13.5 KB


Showing 21-30 of 230	Page: 1 2 3 4 5 ... 23	Previous 10 \| Next 10